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The Crystal Structure of RhoA in Complex with the
DH/PH Fragment of PDZRhoGEF, an Activator of the
Ca2 Sensitization Pathway in Smooth Muscle
mediated inhibition of the myosin light chain phospha-
tase (MLCP). Experiments using permeabilized muscles
that retain G protein-coupled receptors established that
this pathway can also be activated by GTPS while Ca2
is clamped (Kitazawa et al., 1989). Different agonists
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of receptors, but at least one family is activated by G
protein-coupled receptors via an RGSL (RGS-like) do-
main capable of binding the  chain of G12/13 (FukuharaSummary
et al., 1999, 2000; Hart et al., 1998; Kozasa et al., 1998;
Suzuki et al., 2003). This unique family showing distinctCalcium sensitization in smooth muscle is mediated
by the RhoA GTPase, activated by hitherto unspecified homology includes PDZRhoGEF (Fukuhara et al., 1999;
Rumenapp et al., 1999), also known as GTRAP48 (Jack-nucleotide exchange factors (GEFs) acting down-
stream of Gq/G12/13 trimeric G proteins. Here, we show son et al., 2001), p115RhoGEF (Kozasa et al., 1998), and
LARG, or the leukemia-associated RhoGEF (Fukuharathat at least one potential GEF, the PDZRhoGEF, is
present in smooth muscle, and its isolated DH/PH frag- et al., 2000). An RGSL domain was also recently discov-
ered in another, more distantly related exchange factor,ment induces calcium sensitization in the absence of
agonist-mediated signaling. In vitro, the fragment Lbc (Dutt et al., 2004). The crystal structures of the RGSL
domains from PDZRhoGEF and p115 have been solved,shows high selectivity for the RhoA GTPase. Full-
length fragment is required for the nucleotide exchange, and models of interactions with G have been proposed
(Chen et al., 2001; Longenecker et al., 2001), but theas the isolated DH domain enhances it only marginally.
We crystallized the DH/PH fragment of PDZRhoGEF exact mechanism by which this interaction may activate
the nucleotide exchange function of the GEF moleculein complex with nonprenylated human RhoA and de-
termined the structure at 2.5 A˚ resolution. The refined is not known.
All GEFs active on the Rho family of GTPases catalyzemolecular model reveals that the mutual disposition
of the DH and PH domains is significantly different the GDP/GTP exchange by stabilizing the nucleo-
tide-free form of the GTPase, using a tandem of DHfrom other previously described complexes involving
DH/PH tandems, and that the PH domain interacts (Dbl-homology) and PH (pleckstrin-homology) domains,
thereby allowing the more abundant in vivo GTP to re-with RhoA in a unique mode. The DH domain makes
several specific interactions with RhoA residues not place GDP. Many aspects of the molecular mechanism
by which this is accomplished have been revealed byconserved among other Rho family members, sug-
the crystal structures of complexes of the Tiam1 DH-gesting the molecular basis for the observed speci-
PH tandem with Rac1 (Worthylake et al., 2000); the ITSNficity.
(intersectin) DH-PH tandem with Cdc42 and the Dbs
(DH-PH) with RhoA (Snyder et al., 2002); and Dbs (DH-Introduction
PH) with Cdc42 (Rossman et al., 2002). These studies
have shown that while all the residues essential for theIncreased Ca2 sensitivity (or Ca2 sensitization) in
nucleotide exchange process are found in the DH do-smooth muscle is a result of a higher level of phosphory-
main, the PH domain, at least in some cases, contributeslation of the regulatory light chain of myosin, with con-
substantially to the selectivity and specificity of interac-comitant increased tension at constant submaximal
tions.Ca2 concentration. This phenomenon occurs in re-
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PDZRhoGEF (residues 712–1081) could act as the sole
activator of the Ca2 sensitization pathway. The underly-
ing hypothesis was that in the absence of other domains
that might exert downregulation, the DH/PH fragment
should be constitutively active. To test this, a recombi-
nant DH/PH fragment of PDZ-RhoGEF was purified and
used in isometric tension measurements using perme-
abilized rabbit pulmonary artery strips, as described in
Experimental Procedures. The presence of the exoge-
nous DH/PH fragment reproducibly resulted in a signifi-
cant increase in force at constant Ca2 concentration,
pCa 6.7 (16.6  3.3% of the maximal contraction at
pCa 4.5) (Figure 1). Addition of the filtrate of the DH-PH
fragment was without effect on force. The addition of
U46619, an activator of G12/13-coupled thromboxane
A2 receptors, caused a further increase in contraction,
illustrating that agonist-G protein-coupled receptor acti-
vation of the Ca2 sensitization pathway is intact in this
permeabilized muscle preparation. The increase in force
was abolished by the Y-27632 Rho-kinase inhibitor at
10 M concentration, suggesting—as expected—a role
for Rho-kinase in the activation of Ca2 sensitization
mediated by the DH/PH fragment.
Figure 1. Representative Tension Trace Illustrating the Protocol for
Eliciting the PDZRhoGEF-Induced Ca2-Sensitization and Its Inhibi-
The DH/PH Fragment Is Highly Selectivetion by the Rho-Kinase Inhibitor Y-27632 in -Escin Permeabilized
In Vitro for RhoAPulmonary Artery Smooth Muscle.
Having established the physiological effect of the DH/Following permeabilization, submaximal tension was developed in
PH fragment, we asked if the presence of the DH/PHpCa 6.7 solution before addition of 50 M solution of the recombi-
fragment leads to selective activation of the RhoAnant DH-PH fragment of PDZRhoGEF. At the plateau of Ca2 sensiti-
zation induced by the domain, the addition of U46619, a thrombox- GTPase. Although a larger fragment encompassing the
ane A2 analog, caused an additional increase in contraction. DH/PH tandem and the C-terminal domain of PDZRho-
Contraction could be rapidly inhibited by 10 M Y-27632 inhibitor. GEF (residues 637–1522) has been shown to selectively
These data are representative of three experiments. Inset: Western
catalyze the nucleotide exchange for RhoA (Rumenappblot showing evidence of expression of PDZRhoGEF in rabbit pul-
et al., 1999) no rigorous in vitro functional studies weremonary artery smooth muscle.
reported to date for the isolated DH/PH fragment or
the DH domain. Using a fluorimetric assay described in
Experimental Procedures, we measured intrinsic nucle-tion pathway. Indeed, we find that the PDZRhoGEF pro-
otide exchange rates for RhoA, Cdc42, and Rac1, andtein is present in smooth muscle. In this paper, we pres-
then assessed the acceleration of the reaction in theent in vitro and in vivo functional studies of the
presence of either the isolated DH domain, or of therecombinant DH/PH fragment of PDZRhoGEF, as well
intact DH/PH fragment (Figure 2, Table 1). The rate ofas the 2.5 A˚ resolution crystal structure of its complex
exchange increases more than two orders of magnitudewith nonprenylated RhoA. The structure reveals the mo-
for RhoA in the presence of the DH/PH fragment, andlecular details that constitute the basis for the observed
only 7-fold for Cdc42. There is no detectable effect onRhoA selectivity.
Rac1. In contrast, the Dbs DH/PH fragment was reported
to catalyze50-fold enhancements of the reaction rates
Results and Discussion for Cdc42 and RhoA, while intersectin is strictly selective
for Cdc42, with a similar catalytic effect (Cheng et al.,
PDZRhoGEF Is Present in Smooth Muscle Tissue 2002; Rossman et al., 2002; Snyder et al., 2002). Neither
The key role of RhoA in the Ca2 sensitization pathway protein catalyzes nucleotide exchange for Rac.
downstream of G protein-coupled receptors implies the The isolated DH domain is capable of only a 5-fold
presence of a signaling route involving RhoA-specific enhancement of the nucleotide exchange for RhoA, indi-
GEFs interacting with trimeric G proteins. Among few cating that the PH domain plays a critical role for both
potential candidates, PDZ-RhoGEF has been shown by the catalytic function of the GEF and for its selectivity.
others to interact with heterotrimeric G proteins of the In fact, this pattern of PH-assisted catalysis is virtually
G12 family. Here, we have identified PDZRhoGEF in the identical to that observed for Dbs and Trio (Liu et al.,
whole homogenate of rabbit pulmonary artery smooth 1998; Rossman and Campbell, 2000), but unlike inter-
muscle tissue by Western blot analysis, as described in sectin, whose DH domain does not require the PH do-
Experimental Procedures (Figure 1, inset). main for catalysis (Pruitt et al., 2003).
The DH/PH Fragment of PDZRhoGEF Is Sufficient The Crystal Structure of the DH/PH-RhoA Complex:
for Eliciting Ca2 Sensitization An Overview
Given the presence of PDZRhoGEF in the smooth mus- In order to rationalize the observed functional properties
of the DH/PH fragment, we solved its crystal structure incle, we wondered if the isolated DH/PH fragment of
Structure of RhoA Bound to DH/PH of PDZRhoGEF
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the nucleotide binding pocket, consistent with the no-
tion that RhoA is nucleotide-free. In contrast, the PH
domains are less well defined and the mean isotropic
displacement (B) parameters of the DH domains and
RhoA molecules are lower than those of the PH domains
(53 A˚2 for the DH and 63 A˚2 for RhoA versus 87 A˚2
for the PH domains). Thus, each of the PH domains
appears to have a significant degree of freedom within
the crystal lattice in spite of interacting with both its
partner DH domain and the RhoA GTPase. The two com-
plexes differ slightly in the dispositions of the DH and
PH domains relative to the RhoA GTPase. Specifically,
least-squares superposition of the complexes on RhoA
reveals that that the DH domains are minimally rotated
with respect to each other by 2.5 around an axis
approximately perpendicular to the interface. The two
PH domains are rotated by4. These minor conforma-
tional variations do not affect the detailed architecture
of the interfaces discussed in this paper. Furthermore,
the similarity of the two complexes constrained in the
crystal lattice by two different sets of crystal contacts
strongly suggests that the observed conformations are
representative of that in solution. For the purposes of
subsequent analysis, we treat the two complexes as
identical.
As in the other previously reported crystal structures
of similar complexes, the interaction with the DH/PH
fragment alters the local structure of the two functionally
important switch regions in RhoA, thus stabilizing the
nucleotide free form (Figure 3A). The structure of RhoA
in the complex described here is virtually identical to
that described in the Dbs complex (Snyder et al., 2002).
Figure 2. Guanine Nucleotide Exchange Activity of RhoA (1–193)
Both the DH and PH domains show extensive similari-and Cdc42 (1–191) Stimulated by DH Domain and DH/PH Tandem
ties—as expected—to other members of their respec-of PDZ-RhoGEF (In Vitro)
tive families. The DH domain (Figure 3A) is an elongatedThe rate of exchange reaction was monitored by increase in the
helical bundle, as originally described for SOS andmant-GTP fluorescence intensity as a result of its incorporation
to the GTPase, as described in Experimental Procedures. Intrinsic betaPIX (Aghazadeh et al., 1998; Soisson et al., 1998),
exchange activities of RhoA and Cdc42 are shown as a control and assumes a “chaise lounge” shape with all the long
experiment (dark green circles). The rate of nucleotide exchange helices (1a, 2b, 3a, 5b, and 6) packed into the
stimulated by DH domain (red circles) and DH/PH tandem (blue long “seat” and the short helices (3c, 4a, 4b, and
circles) was estimated by linear regression analysis of approximately
5a) in the “seatback.” Here, we follow the standardthe first 50 s after DH stimulation and 12 s after DH/PH stimulation.
nomenclature proposed for these domains by Rossman
et al. (2002) that uses the six major helices as the refer-
complex with the nonprenylated, C-terminally truncated ence points to describe the structure. Among the struc-
RhoA (residues 1–181). The crystals contain two copies turally characterized DH domains, the PDZRhoGEF DH
of the complex within the asymmetric unit. The two are domain is most similar to that of intersectin (PDB entry
very similar and superpose with the rms difference of 1KI1), with which it also shares the highest level of se-
0.93 A˚ for all 533 C atoms. The electron density is well- quence identity (31%), although not the GTPase pref-
defined for most residues in the RhoA molecules and erence (Figure 3B). A total of 208 equivalent C atoms
(out of 226 possible) superpose with an rms differencein the DH domains. No unaccounted density is found in
Table 1. Nucleotide Exchange Rates of Intrinsic, DH-Stimulated, and DH/PH-Stimulated Reactions on RhoA, Cdc42, and Rac1 GTPases
Control a DH-stimulated DH/PH-stimulated
(RFb s1 	 103) (RFb s1 	 103) FSc (RFb s1 	 103) FSc
RhoA (1–193) 1 4.4 4.4 	 136 136 	
RhoA (1–181) 0.6 3 5 	 125 208 	
Cdc42 (1–191) 1.1 1.3 1.2 	 7.8 7.1 	
Rac1 (1–192) 0.7 0.7 1 	 0.7 1 	
a Control experiment indicates intrinsic (nonstimulated) exchange activity of a given GTPase.
b RF–relative fluorescence signal (
ex 356 nm, 
em 445 nm)




Figure 3. The Crystal Structure of the RhoA in Complex with the DH/PH Fragment of PDZRhoGEF and Its Comparison to Complexes with
Intersectin and Dbs
(A) The general features of the DH-domain (green)–RhoA (yellow) interface, with the PH domain (red) at the rear; the two switch regions of
RhoA are shown in purple and labeled; the CR regions of the DH domain are dark green and labeled.
(B) A comparable view of the intersectin’s DH/PH fragment in complex with Cdc42–1KI1.PDB.
(C) A rotated view of the complex shown in A, with the PH domain (red) into the foreground; the unique 4 bulge is shown in turquoise with
the dashed line indicating poorly defined fragment, and dark blue indicates the linker region between the DH and PH domains; the DH domain
in the background is green.
(D) A comparable view of the Dbs DH/PH fragment in complex with RhoA–1LB1.PDB.
of 1.6–1.8 A˚. In contrast, both TIAM1 and Dbs GEFs, from all  strands and the C-terminal helix, among them
the completely buried Leu993, Leu995, Leu1026, Leu1059,acting on Rac and RhoA/Cdc42, respectively, deviate
significantly with pairwise rms differences above 3 A˚ and Ile1045. The PDZRhoGEF PH domain is similar in
its architecture to the PH module of Dbs, with which itand sequence identity levels of 21% for TIAM1 and
24% for Dbs. The closest fit between the DH domains shares23% amino acid sequence identity (Figure 3D).
The superposition of the two domains results in a root-of intersectin and PDZRhoGEF is in the CR1 and CR3
regions. The CR2 region, which is distal to the GTPase mean-square difference of1.6 A˚ on 97 C atoms, with
the  strands and the C-terminal helix showing the high-binding site, fits marginally less well. Thus, the best fit
between the two structures is in the long seat part, while est similarity. A distinctive feature of the PH domain of
PDZRhoGEF is an 18-residue insertion in the 4 strand,the seatback is slightly rearranged.
The PH domain, like other domains in this family, forms between Leu1005 and Pro1024. This insertion is similar
to a special wide (SW) category of -bulges (Chan etan antiparallel  sandwich capped by a short C-terminal
-helix (Rebecchi and Scarlata, 1998). The sandwich is al., 1993), except that Pro1024—which is in the R con-
formation—is an unusual residue at this position. Wemade up of two, nearly orthogonal,  sheets with four
 strands (1–4) in the first, N-terminal  sheet and were unable to find another insertion of this type among
any other PH domains. The resulting bulge in the tertiarythree strands (5–7) in the second  sheet (Figure 3C).
The hydrophobic core contains residues originating fold protrudes into the canonical phosphoinositide bind-
Structure of RhoA Bound to DH/PH of PDZRhoGEF
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ing site and shows high conformational flexibility as significantly to protein-ligand (Pierce et al., 2002) and
protein-protein interactions (Jiang and Lai, 2002). Morejudged by the relatively poor quality of the electron den-
sity, particularly in the solvent exposed fragment. The recently it has been noted that –CH groups within the
indole ring of tryptophans are often donors of suchother major differences between the PH domains of
PDZRhoGEF and Dbs are at the splayed end due to very weak, but structurally important H-bonds (Petrella and
Karplus, 2004). In addition to this weak interaction withdifferent conformations of the 1/2 loop, which is 10
amino acids longer in Dbs, and the 3/4 loop, also Trp58RhoA, Asp873DH also forms an energetically more
important salt bridge with Arg5RhoA. This is one of severalsignificantly longer in Dbs.
It has been noted, that many PH domains are strongly salt bridges that flank the Trp58-centered interface, in-
cluding those formed by Arg868DH with both Asp45RhoApolarized (Lemmon et al., 2002; Macias et al., 1994).
Most canonical PH domains have a positive potential and Glu54RhoA, Arg872DH with Asp76RhoA, and Arg867DH
with Glu40RhoA. Finally, there are a few hydrophobic in-at the “bottom” splayed end of the structure, between
the1/2 and3/4 loops, where they bind phosphoino- teractions in this interface, with the most prominent
one involving Met879DH on one side and Leu69RhoA andsitides. In Dbs, the region of the 1/2 loop contains
five Lys and Arg residues and four more on the 3 and Leu72 RhoA on the other.
An additional interaction involves the switch II region4 strands. In the case of the PDZRhoGEF PH domain,
the 1/2 loop has only three positively charged resi- of RhoA and helix 6 of the DH domain. The side chain of
Arg 68RhoA, a residue conserved among all Rho GTPases,dues counterbalanced by two aspartates. Three more
positive charges are found on the 4 strand, but overall makes a double salt bridge with Glu928DH and Asn929DH.
In addition, the backbone amide of Arg68RhoA donatesthe positive potential is much weaker, suggesting that
phosphoinositol binding may not be a primary function an H-bond to the side chain of Asp921DH. Glu928DH corre-
sponds to Glu1428DH and Glu1239DH in intersectin andof this protein, although no experimental data to confirm
this notion have been reported. In addition, as already TIAM1, respectively, and so the salt bridge may have a
generic significance for these GEFs. In contrast, in eachpointed out, the putative phosphoinositol binding
pocket is partially filled with a long -bulge originating of the Dbs complexes, Arg68 of the GTPase interacts
with the backbone carbonyl of 887DH and with the sidefrom the 4 strand.
chain hydroxyl of Tyr889DH.
The interaction involving switch II and the 6 helix of
The DH-RhoA Interface the DH domain may contribute to the integrity and stabil-
The interface between the DH domain and RhoA is simi- ity of the 6 helix and therefore to the stability of the
lar to that observed in other complexes of this type whole complex. In Dbs, the 6 helix in the DH/PH frag-
involving the DH/PH fragments of TIAM1, Dbs, and inter- ment appears to be stable in both of its complexes
sectin (Karnoub et al., 2001; Rossman et al., 2002; Sny- with GTPases, as inferred from the respective crystal
der et al., 2002). RhoA buries a total of 1,467 A˚2 of solvent structures. In contrast, the structure of the isolated Dbs
accessible surface. The interface is formed primarily by DH/PH fragment shows that in the absence of the
the contacts between the residues in the conserved GTPase the 6 helix may bend away from the body of
regions (CR) CR1 and CR3 of the DH domain and switch the DH domain, thus altering the relative position of the
I of RhoA, and by the contacts between a segment just PH domain; this is seen in two out of four copies of the
preceding and involving the CR3 region and the 6 helix DH/PH molecule in the asymmetric unit (Worthylake et
of DH, and switch II of RhoA (Figure 4). al., 2004). It is possible that the C-terminal part of the 6
The interactions involving switch I of RhoA are generic helix requires stabilization provided by protein-protein
for Rho GTPases, particularly that of Glu741DH with the interactions. The linker connecting the DH and PH do-
backbone amides of Thr37RhoA and Val38RhoA, as well as mains, as well as the PH domain itself, makes several
the side chain hydroxyl of Tyr34Rhoa. These interactions contacts with the C terminus of the 6 helix. To date, no
stabilize the switch I region of all Rho GTPases in the structure is available for any of the isolated DH domains
known complexes in the same conformation. from the relevant DH/PH fragments, and no compari-
The switch II interactions in the known complexes, sons are possible, but it is likely that without the PH
which define the selectivity for the GTPase, are centered domain the conformation of the6 helix might be altered
on a bulky residue on the surface of the GTPase (Trp58 and the interactions with the GTPase would be lost.
in RhoA, Trp56 in Rac, and Phe56 in Cdc42) nested in
a molecular cradle created by a set of residues in the
5a helix of the DH domain. In the present structure this The Orientation of the PH Domain in the Complex
The most significant diversity between the known struc-paradigm is preserved, and the “cradle” is formed by
Leu869DH, Asp873DH, and Ile876DH. Particularly interest- tures of DH/PH GEF fragments in complexes with their
cognate GTPases is in the position of the PH domaining is the side chain of Asp873DH, which is locked into
its conformation by an H-bond accepted by O2 from relative to the DH-GTPase interface. This variation stems
from the differences in the length of the C-terminal (6)the backbone amide of Gln870DH (otherwise unpaired)
and an apparent C-H…O bond from the C2 atom of helix of the DH domain, as well as a rotation of the
PH domain around the 6 helix. The shortest helix—26the indole ring of Trp58RhoA. The C2(Trp58)-O1(Asp73)
distances in the two molecules are 3.2 A˚ and 3.3 A˚ residues—is seen in Dbs (Figure 5A). In other com-
plexes, namely Tiam1, ITSN, and PDZ-RhoGEF, the 6respectively with suitable geometry. The C-H….O bonds
are increasingly recognized as a general structural fea- helix is 10 to 13 amino acids longer. In this regard, the
TIAM1 6 helix is between that of Dbs on the one hand,ture in proteins (Derewenda et al., 1995), contributing
Structure
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Figure 4. The Detailed View of the RhoA-DH Interface
(A) The RhoA switch I (purple) interaction with the 1a and 5b helices (green) of the DH domain; atoms are colored by type except for carbon;
hydrogen bonds are dotted.
(B) A view of the central part of the RhoA-DH interface centered on Trp58RhoA; the color scheme is as in (A), yellow indicates RhoA elements
not involved in switch regions.
(C) Interactions of switch II of RhoA with 6 helix of the DH domain; the color scheme is the same with the PH domain shown in red.
and those of ITSN and PDZ-RhoGEF on the other; it is minal part of the 6 rotates away from the body of the
DH domain pulling behind the PH domain, so that itbent by 120 at position 1240, which makes it compa-
rable—with respect to its effective length—to that of turns away from Rac1 and, consequently, no contacts
are seen between the two (Figure 5B). In the other threeDbs. The other aspect of the molecular architecture is
the rotation of the PH domain around the 6 helix. The structures, the PH domain is turned toward the GTPase.
In Dbs the rotation of the PH domain and the shorterkink in TIAM1 6 makes the situation unique: the C-ter-
Structure of RhoA Bound to DH/PH of PDZRhoGEF
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Figure 5. The Disposition of the PH Domain in Complexes of the DH/PH Fragments with Rho-GTPases
GTPases are shown in yellow, with purple switches; DH domains are in green; PH domain in red; and helix 6 of the DH domain is dark blue.
(A) Two orthogonal views of the Dbs DH/PH complex with RhoA-1LB1.PDB.
(B) TIAM1 DH/PH in complex with Rac1–1FOE.PDB.
(C) Intersectin DH/PH in complex with Cdc42-1KI1.PDB.
(D) The PDZRhoGEF DH/PH complex with RhoA reported in this paper.
length of the 6 helix bring the 3/4 loop into contact structure of the complex reveals several interesting fea-
tures that allow us to hypothesize about the roots ofwith switch 2 of the GTPase. In the intersectin, this
contact is not possible due to length of the 6 helix both high selectivity and activity.
A previous elegant study (Snyder et al., 2002), basedwhich extends16 A˚ further compared with Dbs (Snyder
et al., 2002), despite the fact that the rotation of PH on crystallographic investigations of the complexes of
intersectin and Dbs with Cdc42 and RhoA, respectively,domain in ITSN (Figure 5C) is similar to Dbs. Interest-
ingly, the structure described here resembles intersectin put forward a general proposal for a mechanism of posi-
tive selection of RhoA by GEFs. According to this pro-more than Dbs, because the length of the 6 helix is
virtually identical in the two proteins (Figure 5D). However, posal Trp58RhoA is one of the specificity determinants for
those GEFs that discriminate between Cdc42, whichthe PH domain is rotated by 26 further toward RhoA
compared to intersectin. This is still inadequate to make has Phe in the analogous position, and RhoA. This bulky
residue is seen in the Dbs-RhoA structure to be seques-the 3/4 loop contact switch 2 of the GTPase, as seen
in Dbs and the contacts that the PH domain makes with tered between Leu759DH and Leu766DH, equivalent in
PDZRhoGEF to Leu869DH and Ile876DH. It has beenRhoA are limited to the C-terminal portion of the 3a helix
and in particular Glu97 which is H-bonded to Ser1065 and shown that the Leu766DH →Ile mutation in Dbs substan-
tially increases its catalytic activity on RhoA, from 48-Asn1068 in the C-helix of the PH domain. The associated
buried surface is very limited (260 A˚2) and accounts fold to 267-fold (Cheng et al., 2002), with little impact
on Cdc42 (Cheng et al., 2002). This mutation also confersfor only 8% of the total buried surface in the complex.
In intersectin this fraction is even lower (4%), while in 57-fold rate enhancement on Dbs against Rac (Cheng
et al., 2002). In PDZRhoGEF, the equivalent position isDbs the PH/GTPase interface accounts for over 22% of
the total buried surface. occupied by a RhoA-preferred Ile.
It was also noted (Snyder et al., 2002) that both Asp45
and Glu54 are unique to RhoA, and are replaced byRecognition of RhoA by PDZ-RhoGEF
One of the biologically most important, and medically small and neutral residues in both Rac and Cdc42. All
GEFs active on RhoA have Lys or Arg in a positionmost relevant questions is the molecular basis of the
recognition of target GTPases by GEFs. While many equivalent to Lys758DH of Dbs, which forms a double
salt-bridge with Asp45 and Glu54 (Snyder et al., 2002).GEFs show relative promiscuity with respect to GTPase
activation, the PDZRhoGEF and its homologs show re- Indeed, the PDZRhoGEF has an Arg in this position
(Arg868DH), as do its homologs LARG and p115. Anothermarkable specificity toward RhoA. Furthermore, the ob-
served enhancement of nucleotide exchange activity suggested determinant was Arg5RhoA, which was thought
to make a favorable interaction with a Gln residue inobserved for the DH/PH fragment of PDZRhoGEF on
RhoA is approximately 4-fold higher than any of the RhoA specific GEFs. Our structure shows that Arg5RhoA
is indeed involved, but in a dramatically different way,hitherto reported rates for other DH/PH tandems. The
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Table 2. Crystallographic Data
SeMet
SeMet Peak Inflection SeMet Remote Native
Data collection
Wavelength (A˚) 0.9790 0.97919 0.97178 1.00
Resolution (A˚) 2.6(2.69–2.6)a 2.6(2.69–2.6) 2.6(2.69–2.6) 2.5(2.59–2.5)
No. of total reflections 206,030 174,079 179,000 213,477
No. of unique reflections 98,601 95,011 96,264 58,062
Completeness (%) 97.7 (87.5) 94.3(71.5) 94.0 (63.5) 97.4 (83.1)
Rmerge (%)b 4.6 (45.3) 4.2 (35.5) 4.2 (38.0) 5.5 (28.1)
I/(I) 17.6 (1.7) 16.5 (2.0) 16.1 (1.8) 21.5 (4.0)
Phasing statistics
Phasing powerc, iso/ano 0.7/1.7 1.3/1.0 –/1.1
Refinement statistics
Model Composition 1069 residues  90 waters
Resolution limits (A˚) 25–2.5
Reflections in working/test sets 54,415/2,899
Reflections in final refinement 57,314
R§/Rfree (%) 22.4/28.1
Final Rd (%) using all data 23.5
Bond(A˚)/angle() rms 0.011/1.268
Ramachadran plot
Most favored regions 90.2%
Additional allowed regions 8.8%
a The numbers in parentheses describe the relevant value for the last resolution shell.
b Rmerge |Ii  I|/I where Ii is the intensity of the i-th observation and I is the mean intensity of the reflections.
c Phasing power  rms (|Fh|/E), where |Fh| is the heavy atom structure factor amplitude and E is residual lack of closure error.
d R  ||Fobs|  |Fcalc||/|Fobs|, crystallographic R factor, and Rfree  ||Fobs|  |Fcalc||/|Fobs| where all reflections belong to a test set of randomly
selected data.
i.e., by swinging inside the interface to make a salt- and PC-3 prostate cancer cells, the thrombin receptor
activates RhoA via LARG, while the LPA stimulation ofbridge with a buried Asp873DH. A perusal of known se-
quences of GEFs indicates that this residue may indeed RhoA is due to PDZRhoGEF (Wang et al., 2004). Thus,
the RGSL-containing family of nucleotide exchange fac-constitute an important determinant. It is found in this
position in all three members of the PDZRhoGEF family, tors emerges as a physiologically important and ubiqui-
tous class of signaling molecules. The 2.5 A˚ resolutionand also in Lsc, Trio/C, Vav, and Vav2, all of which are
active on RhoA. Further, Lbc and Lfc, both of which are crystal structure of the complex of the DH/PH fragment
with RhoA, reported here, reveals an extensive and spe-known to act on RhoA (Glaven et al., 1996) have a Glu
in this position, suggesting a similar function. cific interface between the DH domain and the GTPase,
fully rationalizing the observed specificity and selectivityIn addition to these predicted interactions, our struc-
ture reveals additional features that may substantially of PDZRhoGEF and its homologs. In addition to the
expected interactions involving Trp58 of RhoA and theenhance the selectivity and activity of PDZRhoGEF and
its homologs. Of particular interest are two salt bridges, residues in the 5 helix of the DH domain, we identified
several other interactions unique for RhoA, notablyArg872DH with Asp76RhoA and Arg867DH with Glu40RhoA.
Position 872 is occupied in the PDZRhoGEF family GEFs those involving Arg5, Asp76, and Asp40. Further muta-
tional studies will establish the individual contributionsby Arg or Lys, and a favorable interaction is possible
uniquely with RhoA, because the position equivalent to of these interactions to the overall selectivity of
PDZRhoGEF and other members in this family. The PHthe charged Asp76 is occupied by a neutral Gln in both
Cdc42 and Rac. Arg867DH is conserved among the domain makes contact with RhoA, but the resulting in-
terface is small, and it is not immediately obvious if thePDZRhoGEF family members, and the position is often
occupied by positively charged residues in other GEFs PH domain participates directly in catalysis, as seems
to be suggested by the in vitro nucleotide exchangeacting on RhoA, such as Lbc or Lfc. Altogether, the
PDZRhoGEF–RhoA interface contains a number of assays. The structure suggests, however, that the PH
domain might be involved indirectly, by providing stabili-highly selective interactions, involving a number of salt
bridges, exploiting the unique electrostatic potential zation to the C-terminal part of the 6 helix of the DH
domain. Further experiments, under way in our labora-surface of RhoA.
tories, will resolve this issue.
While this paper was being reviewed, a study of aConclusion
related complex involving the DH/PH fragment of LARG
was published online ahead of print (Kristelly et al.,In this paper, we present evidence that PDZRhoGEF
is a likely candidate to serve as a molecular coupling 2004). In spite of significantly lower resolution of data
than those reported here (i.e., 3.2 A˚ versus 2.5 A˚), thebetween G protein-coupled receptors and RhoA in
smooth muscle, with a potentially critical role in Ca2 authors observe a mutual disposition of the DH/PH and
RhoA molecules that appears to be consistent with oursensitization. It was recently shown, that in the HEK 293T
Structure of RhoA Bound to DH/PH of PDZRhoGEF
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cedure (Hiratsuka, 1983). The exchange reaction was carried out atresults. Detailed comparison will be possible upon the
21C, in a quartz cuvette containing 1 M GDP-preloaded RhoA,release of the coordinates.
Cdc42, or Rac1, and 500 nM mant-GTP in 20 mM Tris-HCl, [pH 7.5],
50 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 5% glycerol, continuouslyExperimental Procedures
stirred at 450 rpm. After 300 s equilibration time, the DH domain
or DH/PH tandem was added at 100 nM and the mant-GTP fluores-Expression and Purification
cence increase was monitored (
ex  356 nm, 
em  445 nm) as aThe DH/PH fragment (residues 712–1081) and DH domain (residues
result of its incorporation to the GTPase. The control experiment729–939) of human PDZ-RhoGEF were expressed as fusion proteins
reflects intrinsic exchange activity of a given GTPase, measuredwith GST in BL21(DE3)-RIL E. coli strain (Stratagene). Both fusion
after equivalent equilibration time. Each exchange experiment wasproteins were purified as described previously (Oleksy et al., 2004),
carried out three times independently. The initial rates of guanineexcept for using an anion exchanger HiTrap Q Sepharose (Amer-
nucleotide exchange were determined by linear regression analysissham Pharmacia Biotech) instead of Superdex-75 size exclusion
of approximately the first 50 s after DH stimulation and 12 s aftercolumn (Amersham Pharmacia Biotech). The purified DH/PH and
DH/PH stimulation. Although the rates for RhoA were previouslyDH proteins were concentrated in 50 mM Tris-HCl, [pH 7.5], 20 mM
reported by us (Oleksy et al., 2004), they were repeated in this studyNaCl, and 1 mM DTT. Human full-length RhoA (residues 1–193),
to ensure that the experimental conditions were identical to thosetruncated RhoA (residues 1–181), full-length Cdc42 (1–191 aa), and
for Rac and Cdc42. The discrepancies between the two sets of datafull-length Rac1 (residues 1–192) were expressed in pETUni vector
are due to the higher level of purity of the DH-PH fragment in this(Sheffield et al., 1999) in fusion with a His6-tag also in BL21(DE3)
study.RIL. The GTPases were purified by Ni-NTA-agarose affinity chroma-
tography in 50 mM Tris-HCl, 400 mM NaCl, 1 mM MgCl2, 5 mM
Tissue Preparation and Isometric Tension Measurementsimidazole, [pH 8.0], and eluted with 150 mM imidazole buffer. Final
Male white New Zealand Rabbits (2–3 kg) were anesthetized bypurification was carried out using gel filtration. Before fluorescence
overdose with halothane. Pulmonary artery was removed, placedexchange assays, bacterially expressed RhoA, Cdc42, and Rac1
into warm HEPES-buffered Krebs solution, [pH 7.3]. The connectivewere incubated with excess GDP (ICN Biomedicals, Inc.) in the
tissue and adventitia were carefully removed and thin strips (100–presence of EDTA. After 1 hr, excess of MgCl2 was added and the
200 M wide and 1–2 mm long) were dissected and stretched byunbound nucleotide was removed using a HiPrep desalting column
10% of resting length. Isometric tension was measured with a force(Amersham Pharmacia Biotech).
transducer (AE801; Akers, Horten, Norway) on a “bubble” plate (Kita-The SeMet labeled DH/PH tandem was expressed using the
zawa et al., 1989). Strips were incubated in a Ca2-free normal re-pHis6MBP vector (gift from Dr. D. Waugh, NCI) and the Met auxo-
laxing solution containing 1 mM EGTA (G1) and permeabilized withtroph DL41 E. coli strain. The cultures were grown in the LeMaster
-escin (75M) for 30 min at 22C. To deplete the sacroplasmicmedia at 37C. Protein expression was induced at a high OD600
reticulum of calcium, all permeabilized strips were treated withof 3.5 with 1 mM IPTG. The cultures were incubated at room
A23187 (10 M; Calbiochem, La Jolla, CA) for 10 min in relaxingtemperature for 24 hr. The cells were harvested by centrifugation.
solution (Kitazawa et al., 1989; Kobayashi et al., 1991). PermeabilizedThe pellet was resuspended in lysis buffer (50 mM Tris-HCl, [pH
strips were incubated with a solution containing 10 mM EGTA and7.5], 300 mM NaCl, 5 mM Met, and 10 mM imidazole) and disrupted.
sufficient Ca for a final free pCa 6.7. Following incubation, the DH/The supernatant was incubated at 4C with Ni-NTA (Qiagen) resin
PH domain of PDZ-RhoGEF (50 M) or filtrate was added to thefor 1 hr. After washing the resin with 4 liter of lysis buffer, the protein
pCa 6.7 solution and force was observed. The pretreatment of thewas eluted in 1 ml fractions with elution buffer (lysis buffer containing
strips with A23187, buffering with EGTA as well as the lack of effect150 mM imidazole). Fractions containing the HisMBP-DH/PH fusion
of the filtrate, assert that the changes in force were not due toprotein were incubated overnight with the rTEV proteinase (Kapust
changes in Ca2 concentration.et al., 2001) at 10C. After removal of imidazole using a desalting
column, the SeMet labeled DH/PH was separated from cleaved
Crystallization and Data CollectionHisMBP using Ni-NTA resin as described above. The concentrated
The SeMet DH/PH–RhoA crystals were grown by vapor diffusion inprotein was further purified using size-exclusion chromatography
hanging drops at room temperature by adding 1.5 l of well solutioncolumn (Superdex 200 16/60, Amersham Pharmacia Biotech) and
(200 mM tripotassium citrate [pH 7.9], 21% PEG 3350, 0.5 mM EDTA,mixed with excess amount of F25N mutant of truncated RhoA. The
and 2 mM TCEP) to 1.5l of protein complex at 12 mg/mL concentra-sample was dialyzed against 20 mM Tris-HCl, 150 mM NaCl, 1 mM
tion. The crystals grew to average dimensions of 0.2 mm	 0.2 mm	DTT, and 5 mM EDTA [pH 7.1] overnight at 4C in order to remove
0.2 mm within 2 weeks. The best cryosolution proved to be 32%Mg2 and the nucleotide. The SeMet DH/PH–RhoA complex was
PEG 3350, 16% glycerol, and 500 mM KI, with KI greatly improvingpurified from excess of RhoA using Superdex 200 size-exclusion
the diffraction quality. For data collection, the largest crystal 0.4 	column equilibrated with 20 mM Tris-HCl, [pH 7.2], 150 mM NaCl,
0.2 	 0.24 mm was transferred to the cryosolution and frozen. Theand 1 mM TCEP.
crystals belong to space group, P21, a  87.9 A˚, b  118.8 A˚, c 
88.7 A˚, and   113.5. A MAD data set was collected on beamlineWestern Blot Analysis for PDZ-RhoGEF
X9B at the NSLS (Brookhaven National Laboratory) at Se absorptionSupernatants from whole tissue homogenate were solubilized in 1	
peak (
1 0.9790 A˚), edge (
2  0.97919 A˚) and a remote wavelengthLaemmli sample buffer and clarified (800 	 g, 10 min) before SDS-
(
3  0.97178 A˚). Data were integrated and scaled using HKL2000PAGE. Homogenates were run on 10% SDS-PAGE and were trans-
(Otwinowski and Minor, 1997).ferred to PVDF (polyvinylidene difluoride) membranes. Membranes
were blocked with 5% nonfat dry milk in phosphate-buffered saline
containing 0.05% Tween-20 (PBS-T) for 1 hr at room temperature. Phasing, Model Building, and Refinement
Fourteen out of sixteen Se atoms were located using anomalousMembranes were incubated overnight at 4C (1:1000) in a polyclonal
primary antibody for PDZ-RhoGEF prepared in rabbit, a gift from differences by SHELXD (Schneider and Sheldrick, 2002). MAD
phases were calculated and refined in SHARP (Fortelle and Bri-Dr. Silvio Gutkind, followed by washing in PBS-T and incubation
with horseradish peroxidase-conjugated secondary antibody to rab- cogne, 1997) using remote wavelength as the reference dataset.
Fourier maps were used to locate the remaining two selenium atoms.bit for 1 hr at room temperature and developed with enhanced
chemiluminescence (ECL, Amersham Pharmacia Biotech). Membranes Solvent flattening was performed using Solomon and DM as imple-
mented in SHARP. These phases were sufficient to trace most ofwere stripped and reblotted with a smooth muscle anti--actin anti-
body to normalize for protein load. RhoA molecules and DH domains. Only partial models of the PH
domains were traced at this stage since the electron density for
these regions remained poorly defined. Multidomain averagingGuanine Nucleotide Exchange Assay
Fluorescence spectroscopic analysis using the N-methylanthraniloyl- made it possible to build the remainder of the structure. The NCS
averaging was performed using RAVE (Kleywegt and Jones, 1994).GTP (mant-GTP) was performed with a Jasco FP-750 spectrofluo-
rimeter. Mant-GTP was synthesized according to the published pro- Program O (Jones et al., 1991) was used for model building and
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Refmac5 (Murshudov et al., 1997) for refinement. NCS restrains were the guanine nucleotide exchange activity of p115 RhoGEF by G13.
Science 280, 2112–2114.applied throughout the refinement. The final refinement was carried
out using native data at 2.5 A˚ resolution. At the stage when Rcryst Himpens, B., Kitazawa, T., and Somlyo, A.P. (1990). Agonist-depen-
was 22.4% and Rfree was 28.1%, the model was refined against all dent modulation of Ca2 sensitivity in rabbit pulmonary artery
reflections. The final model contains 9252 atoms (8661 protein and smooth muscle. Pflugers Arch. 417, 21–28.
591 solvent atoms). The model has 90.3% of all residues in the core
Jackson, M., Song, W., Liu, M.Y., Jin, L., Dykes-Hoberg, M., Lin,region of the Ramachandran plot with no residues in the disallowed
C.I., Bowers, W.J., Federoff, H.J., Sternweis, P.C., and Rothstein,regions. The mean temperature (B) factor for all atoms is 65.8 A˚2
J.D. (2001). Modulation of the neuronal glutamate transporter EAAT4(Table 2).
by two interacting proteins. Nature 410, 89–93.
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